Navigation Links
Iomai Dose-Ranging Trial Demonstrates Needle-Free Patch Vaccine for,Travelers' Diarrhea Stimulates Immune Response Even at Low Doses

-- Data Gathered to Assist in Design of Future Trials, Other Programs --

GAITHERSBURG, Md. and LISBON, Portugal, April 26, 2007 /PRNewswire-FirstCall/ -- Iomai Corporation today announced results from a 400-patient, Phase 2 dose-ranging trial of its patch-based vaccine for travelers' diarrhea. The trial was conducted to assess the ability of a range of vaccine doses to generate an immune response against enterotoxigenic E. coli (ETEC) bacteria -- the most common cause of travelers' diarrhea. Researchers found that even at the lowest dose tested, an Iomai patch applied to the arm generated a robust response in more than 95 percent of patients.

The results were presented today by Iomai's Vice President of Clinical Development, Sarah A. Frech, DVM, at the Vaccines for Enteric Diseases 2007 conference in Lisbon, Portugal.

"These results demonstrate the power of Iomai's technology by showing that even a small dose of vaccine, applied to the skin via a patch, is enough to stimulate a robust immune response. The data will help us determine the dose that we will use in our ETEC product," said Gregory M. Glenn, MD, Senior Vice President and Chief Scientific Officer of Iomai. "Iomai's research has shown that, in addition to showing potential benefits against ETEC, the active ingredient in the patch also works as an immune-boosting adjuvant when the patch is used in combination with injected vaccines for influenza. Thus, the results from the dose-ranging ETEC study will also help determine doses for future studies of the Iomai booster patch for seasonal and pandemic influenza."

Travelers' diarrhea sickens between 20 and 50 percent of international travelers to areas where the bacteria is endemic, but no ETEC vaccine is available in the United States. The existing strategy for avoiding travelers' diarrhea -- prophylactic antibiotics -- raises concerns about antibiotic resistance and drug side effects.<
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Iomai to Announce Results From Phase 1 Influenza Trial and Host Webcast Tomorrow
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
7. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
8. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
9. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
10. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
11. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
Post Your Comments:
(Date:9/18/2014)... Mass. , Sept. 18, 2014  Spring ... novel therapeutics for the treatment of RNA viruses, ... Institutes of Health (NIH) for animal testing of ... viral pathogens, classified as "Special Pathogens," against which ... 9200, derived from Spring Bank,s proprietary ...
(Date:9/18/2014)... 18, 2014  RXi Pharmaceuticals Corporation (NASDAQ: ... focused on discovering, developing and commercializing innovative ... RNA-targeted technologies, today announced that the Company,s President ... Cauwenbergh , will present at the 7 ... Wednesday, September 24, 2014 at 11:20 a.m. ...
(Date:9/17/2014)... DALLAS , Sept. 17, 2014 /PRNewswire-iReach/ -- ... Methyl Methacrylate (MMA) Industry" and "2014 Market Research ... research reports to its store. Photo ... Market Research Report on Global Methyl Methacrylate (MMA) ... on China and Global ...
Breaking Medicine Technology:Spring Bank Pharmaceuticals Announces NIH Collaboration for Testing of SB 9200 Against Multiple Viral Pathogens 2RXi Pharmaceuticals to Present at the 7th Annual BioPharm America Conference 2RXi Pharmaceuticals to Present at the 7th Annual BioPharm America Conference 3Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 2Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 3Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 4Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 5
(Date:9/18/2014)... 18, 2014 -- Only about half of all pregnant ... leaving thousands of moms-to-be and their babies at increased risk ... should be a routine part of prenatal care," said Edward ... providers should offer their pregnant patients a flu shot each ... it." , A report by the U.S. Centers for Disease ...
(Date:9/18/2014)... German . In ... fight a pathogen tooth and nail, but rather tolerate it to ... of tolerance is that the disease only progresses very slowly ... pathogen load. , Roland Regoes, a senior scientist at ETH Zurich,s ... He set about investigating whether there are infected people who are ...
(Date:9/18/2014)... CRDF Global released today its ... edition – rich with videos, images and interactive ... Global empowers scientists and innovators around the world. ... foundation and individual supporters, CRDF Global reaches across ... training and entrepreneurship. , The Annual Report highlights ...
(Date:9/18/2014)... Africa (PRWEB) September 18, 2014 Phela ... adopt the HABIT™ Program in South Africa. ... Health and Wellness, and distributed in South Africa by ... the HABIT program, which has been tailored to address ... HABIT™ focuses on behavior modification and chronic disease prevention. ...
(Date:9/18/2014)... new expert panel report, Improving Medicines for Children ... Canadian Academies, addresses the importance of developing safe ... half of Canada,s seven million children use at ... is done off-label (i.e. the prescription differs from ... have historically been excluded in drug research and ...
Breaking Medicine News(10 mins):Health News:Flu vaccine for expectant moms a top priority 2Health News:Withdrawal from the evolutionary race 2Health News:Withdrawal from the evolutionary race 3Health News:CRDF Global Launches Media-Rich Digital Edition of Annual Report, Tells Story of Empowering Scientists and Innovators around the World in 2013 2Health News:Improving medicines for children in Canada 2
... Event at Penn State Hershey to Launch 2008 ... Thousands of,Pennsylvania taxpayers who participate in the ... Research deserve recognition for the,thousands of dollars in ... year. On Monday, February 11 at 9:30 a.m., ...
... Montreal, 6 February 2008 - A recent study by ... Health Centre research Institute, sheds some new light on ... Hastons study is pointing at genetics as contributing to ... implications in changing therapeutic practices. The article was published ...
... ) announced today that its Chief Executive Officer, Mark,McAndrew, and Chief Financial Officer, ... Conference in,New York City. Torchmark,s presentation is scheduled to begin at 2:20 p.m.,EST., ... The presentation will be webcast live at:, ... http://www.torchmarkcorp.com ...
... Group on,Health (NBGH) and the Office of Minority Health ... 2008 at 1:30 p.m. EST to announce a new,initiative ... improve the quality of health care for a culturally ... and public health,together to develop guidance and strategies for ...
... Tobacco-Free Kids, WASHINGTON, Feb. 7 The World ... clear both,the devastating scope of the global tobacco epidemic ... the world today - and the fact that it ... presents the first comprehensive picture of what the world,s ...
... February 19, 9 a.m. - 5 p.m.), SCOTTSDALE, ... Children,s Dental Health Month. Dr. Lee Weinstein, a ... Associates for Kids Only, will be offering a Free ... a.m. until 5 p.m., The first 30 patients that ...
Cached Medicine News:Health News:The Pennsylvania Breast Cancer Coalition Announces 2008 Breast Cancer Income Tax Check-Off Grant Recipients 2Health News:Landmark WHO Report on Global Tobacco Epidemic Should Spur Urgent Action by Nations to Implement Proven Solutions 2Health News:Landmark WHO Report on Global Tobacco Epidemic Should Spur Urgent Action by Nations to Implement Proven Solutions 3Health News:Free Children's Dental Day; Expert Source on Children's Dental Health Available 2
Straight shafts with 0.5 mm teeth and 6 mm tying platform. Wide serrated handle with thumb catch lock and polished finish....
Straight shafts with 0.12 mm teeth and tying platform. Serrated handle with polished finish....
Heavy curved shafts with 2 x 2 teeth and crisscross serrated 6 mm tying platform. Serrated handle with polished finish....
Straight shafts with 5.5 mm tying platform. 0.3 mm gap at platform heel. True round knurled handle in the closed position. Polished finish. Tips: 0.12 mm teeth....
Medicine Products: